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Background and purpose: Radiation-induced cerebral cavernous malformation reflects post-irradiation
impairment of cerebral microcirculation. Our purpose was to determine effects of radiation field size
and dose on the extent of developing cavernous malformations in long-term survivors of intracranial
germ cell tumors (GCTs).
Methods: The study involved 34 patients with a history of intracranial GCTs treated with either whole-
brain or reduced-field irradiation and undergoing magnetic resonance (MR) imaging with a mean
follow-up of 18.5 years. The number of cavernous malformations on T2*-weighted MR images between
whole-brain and reduced-field irradiation groups as well as between high- (50.2 Gy) and low-dose
(24.4 Gy) fields were compared.
Results: A total of 235 cavernous malformation lesions were observed in 32 of 34 patients (94.1%). The
mean number of lesions was 2.3 times as high in the whole-brain group as in the reduced-field group
(P = 0.00296). The number of lesions in high-dose fields was significantly larger than in low-dose
(P < 0.000001) or untreated fields (P < 0.001).
Conclusion: Radiation field size and dose were positively associated with the number of cavernous mal-
formations developed. Cavernous malformations detected on MR imaging can be used as a surrogate
marker for microvascular injury following intracranial irradiation in long-term cancer survivors.
 2015 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 117 (2015) 302–307
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Intracranial germ cell tumors (GCTs) are a heterogeneous group
of tumors and are subclassified into germinomas and nongermino-
matous GCTs; most of them are radiosensitive and generally have
an excellent prognosis and good long-term survival [1]. In western
countries, intracranial GCTs represent 0.4–3.4% of all pediatric
brain tumors, while studies from Japan have reported that GCTs
account for up to 11% of pediatric brain tumors [2]. Controversy
remains regarding the optimal management of intracranial GCTs
[2,3]. Whole-brain irradiation plus boost is still used as a primary
treatment approach so as to maintain a high cure and low relapse
rate [4–6], but there have been suggestions that reduced-field irra-
diation could be adequate for a cure [7,8]. There is concern aboutthe late toxic effects that might arise from irradiation of a large vol-
ume in the young-age group [9].
Cognitive impairment has been reported to occur in 40–50% of
long-term cancer survivors after treatment with whole-brain irra-
diation [10,11]. The specific etiology of these neurocognitive defi-
cits has not been established. However, some evidence suggests
that radiation-induced cognitive impairment is linked to vascular
endothelial cell loss, capillary occlusion, proliferative and degener-
ative glial reactions and demyelination [12–14]. The vascular
hypothesis, which posits radiation-induced vascular injury, is
probably the most recognized and most long-standing premise as
the primary cause of radiation-induced cognitive impairment [12].
Radiation-induced vascular injury is often classified into two
types: large arterial injury and cryptic vascular malformation.
Large arterial injury likely represents atherosclerotic changes in
larger arteries [15], whereas cryptic vascular malformations of
the brain may reflect post-irradiation impairment of cerebral
microcirculation [16,17]. The latter appear as hypointense foci on
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gradient-echo images and have been called either telangiectasias
[16] or cavernous malformations [18]. Because their clinical behav-
ior and pathologic characteristics are often similar to those of
spontaneous cavernous malformations [19–21], we call them
radiation-induced cavernous malformations (RI-CMs). RI-CMs
were first reported in 1994 [22]; since then, additional cases have
appeared in the literature. However, whether there is any quanti-
tative relationship between radiation field size and dose on the
development of RI-CMs remains unclear [23].
The purpose of the present study was to determine effects of
radiation field (whole-brain versus reduced-field irradiation) and
radiation dose (high- versus low-dose fields) on the extent of
developing cavernous malformations in long-term survivors of
intracranial GCTs.
Materials and methods
Patients and groups
The institutional ethics review board approved this retrospec-
tive cohort study and waived informed consent. A review of med-
ical records from the radiation oncology department of a single
institution between January 1983 and December 1996 identified
79 patients with newly diagnosed intracranial GCT. The study
enrolled 34 consecutive subjects (29 males and five females aged
8–44 years; mean age, 15.2 years; median age, 14.0 years) who
had received radiotherapy during the above period and underwent
long-term follow-up with brain MR imaging at least 10 years after
completion of irradiation. The 34 patients included 30 germinomas
and four non-germinomatous GCTs: 13 were pathologically veri-
fied GCTs and 21 were not pathologically verified but were diag-
nosed as GCTs by clinical and neuroradiologic diagnostic signs.
The diagnostic signs of GCT [24] included age within the typical
range (8–32 years, with approximately 90% occurring before age
20 years), tumor site (usually located in suprasellar and/or pineal
regions), characteristic CT and MR imaging findings, serum and/
or cerebrospinal fluid levels of HCG, b-HCG and a-fetoprotein
and response to radiotherapy. In 13 patients (38.2%), the primary
site of the GCTs was the pineal region and in eight patients
(23.5%), the primary site was the suprasellar region. Nine patients
(26.5%) had multifocal tumors involving both pineal and suprasel-
lar regions. Four patients (11.8%) had tumors in the basal ganglia.
All 34 patients underwent extended-local irradiation including
the third and lateral ventricles as well as the suprasellar and the
pineal regions [25]. Of them, twenty patients additionally under-
went whole-brain irradiation. Therefore, our subjects were divided
into two groups according to the radiotherapy received: (a) com-
bined whole-brain and extended-local irradiation (whole-brain
group; 50.2 ± 1.6 Gy; n = 20); and (b) extended-local irradiation
alone (reduced-field group; total dose, 53.5 ± 2.3 Gy; n = 14).
Between the whole-brain and reduced-field groups, there were
no significant differences in the total dose of radiation receivedTable 1
Patient characteristics.
Patient Radiation
field*
Total radiation dose
(Gy)
Age at
irradiation
Whole-brain group (n = 20) WB, Ex-L 50.2 ± 1.6 14.1 ± 0.7
Reduced-field group
(n = 14)
Ex-L 53.5 ± 2.3 16.2 ± 2.6
P = 0.260 P = 0.751
Note: Thirty-four patients were divided into two groups based on radiation field: a co
extended-local irradiation alone (reduced-field group). Differences in patient characteri
Mann–Whitney U test.
* WB = whole-brain irradiation; Ex-L = extended-local irradiation.(P = 0.260), age at initial irradiation (P = 0.751) and administration
of adjuvant chemotherapy (P = 0.409) or surgical intervention
(P = 0.171). Patient characteristics are summarized in Table 1.Details of radiation therapy
Radiation therapy was administered using a 10-MV linear accel-
erator. The treatment technique used for whole-brain irradiation
was conventional two-dimensional (2D) helmet-field irradiation.
The size of radiation fields ranged from 12  17 cm2 to
19  20 cm2 (mean field size, 17.0  18.2 cm2). The treatment
technique used for extended-local irradiation was two parallel-
opposed fields, with radiation fields ranging from 6  6 cm2 to
10  13 cm2 (mean field size, 7.8  10.1 cm2). Daily fractions of
2.0 Gy were administered to the primary tumor, 5 days/week.
Daily fractions of 2.4 or 2.6 Gy were administered in two patients.MR imaging
Routine follow-up MR imaging surveillance to assess for tumor
recurrence and complications of radiation therapy included axial
T1-weighted spin-echo (T1WI), axial T2-weighted fast spin-echo
(fast-SE T2WI) and axial gadolinium-enhanced (Magnevist, Scher-
ing AG, Berlin, Germany) T1-weighted spin-echo (post-contrast
T1WI) sequences, which were performed in all patients every 1–
2 years. From 2006 onward, an axial T2*-weighted gradient-echo
sequence (T2*GRE) was added to the routine follow-up protocol.
The T2*GRE images were available for all patients and were
acquired 4.4 times on average per subject between 2006 and
2013. The most recent T2*GRE images (TR/TE = 600/26 ms, flip
angle 30, 6.0-mm sections, 1.0-mm intersection gap) acquired
with a 1.5 T MR imaging system (Signa Horizon LX CV/I; GE Med-
ical System, Milwaukee WI, USA) were analyzed for RI-CM. The
mean follow-up period from completion of irradiation to RI-CM
analysis was 18.5 years (range, 11.3–25.6 years) and there was
no difference between the groups (P = 0.146). MR angiography
(MRA) was acquired at least once in all the subjects.Assessment of three anatomical zones on MR images and their
presumed relationship to high- and low-dose radiation fields
All axial MR images were divided into three zones (zones 1, 2
and 3) in an axial plane nearly parallel to the AC-PC line from ver-
tex to base (Fig. 1). The superior border of the corpus callosum and
the superior aspect of the middle cerebellar peduncle were used as
anatomic landmarks for the superior and inferior borders of zone 2.
Zone 2 was roughly equivalent to the ventricular level. Zone 1
included supraventricular structures (including a transverse sec-
tion through the superior border of the corpus callosum) and zone
3 contained most of the infraventricular structures (including a
transverse section through the middle cerebellar peduncle). The
field of extended-local irradiation was encompassed by zone 2,
whereas the field of whole-brain irradiation included zones 1, 2Underwent
chemotherapy
Underwent
surgery
Follow-up period
(y)
10 7 19.3 ± 0.9
5 2 17.4 ± 1.1
P = 0.409 P = 0.171 P = 0.146
mbination of whole-brain and extended-local irradiation (whole-brain group) vs.
stics between the two groups were assessed by using the Fisher’s exact test or the
Fig. 1. The three anatomical zones on MR imaging and their relationship to high-
and low-dose radiation fields. Based on two anatomic landmarks, the superior
border of the corpus callosum and the superior aspect of the middle cerebellar
peduncle, the whole brain was divided into three anatomic zones along the long
axis. Zone 2 was roughly equivalent to the ventricular level, and included the field
of extended-local irradiation (blue color box). The sum of zone 1, zone 2 and zone 3
was considered to be equivalent to the field of whole-brain irradiation (red box).
Zone 2 received high-dose radiation, whereas zones 1 and 3 received low-dose
radiation (in the whole-brain group) or no radiation dose (in the reduced-field
group).
304 Radiation-induced cerebral cavernous malformationsand 3. The whole-brain group received whole-brain irradiation in
combination with extended-local irradiation, with zone 2 conse-
quently receiving a higher dose (50.2 ± 1.6 Gy) as compared with
zones 1 and 3 (24.4 ± 1.1 Gy).MR image evaluation
MR image evaluation was conducted by two neuroradiologists
(L.L. and S. M., with 9 and 23 years of experience, respectively),
who were each blind to the subjects’ identities. The most recent
MR images including T2*GRE obtained on the 1.5 T GE MR imaging
systemwere used for analysis. MR imaging inclusion criteria for RI-
CMs was very-low-signal-intensity foci (P2 mm in diameter),
indicating hemosiderin deposits, on T2*GRE images. The number
of RI-CMs in each anatomic zone was counted independently by
the two neuroradiologists. Any initial disagreements in interpreta-
tion were resolved by consensus. We ignored the possibility of
microbleeds resulting from hypertension or cerebral amyloid
angiopathy because all cases were in young adult patients. To
exclude sites of treatment-related hemorrhage or post-radiation
mineralization foci that could mimic RI-CMs, we excluded regions
around the primary tumor bed and areas of surgical intervention,
the basal ganglia and the dentate nuclei from the evaluation.
Other radiologic sequelae, including cerebral infarction, occlu-
sion of major artery, white matter T2 hyperintensities, atrophy
and meningioma, were also evaluated.Analysis and statistics
To determine effects of radiation field size on the extent of RI-
CMs, we analyzed differences in the number of RI-CMs between
whole-brain and reduced-field groups using the Mann–Whitney
U test. To determine effects of radiation dose, differences in the
number of RI-CMs among zones in each group were examined
using Tukey’s Honest Significant Difference (HSD) test. The Poisson
regression model was applied because the number of RI-CMs is a
non-negative integer. To account for baseline differences in indi-
vidual patients, the random effect was introduced to the Poisson
regression model. Combining the random effect with the Poisson
regression, the generalized linear mixed effect model (GLMM) withPoisson family was used for the analysis. The statistical analyses
were performed using R 3.1.1 with MASS, lme4, and glht packages.
The statistical significance was defined as a two-sided P-value less
than 0.05. All measurements were presented as mean ± standard
error of the mean (SEM) values and median values.Results
Thirty-two (94.1%) of the 34 patients developed a total of 235
RI-CM lesions. Of the 235 lesions, 50 were detectable on both
T2*GRE and fast-SE T2WI sequences, while the other 185 were
detectable only on the T2*GRE sequence (Fig. 2). The data acquired
with T2*GRE were used for statistical analysis.
Though there was no significant difference in the prevalence
(presence or not) of RI-CMs between the whole-brain and
reduced-field groups (20 of 20 cases in the whole-brain group ver-
sus 12 of 14 cases in the reduced-field group, P = 0.162), the mean
number of RI-CMs per patient was 2.3 times as high in the whole-
brain group as in the reduced-field group (mean, 9.0 ± 1.3 versus
3.9 ± 1.0; median, 7.5 versus 2.5, P = 0.00296), as shown in Fig. 3.
We further evaluated whether there was a difference in the
number of RI-CMs among zones in each group (Fig. 4). In the
whole-brain group, in which zone 2 received high-dose exposure
(50.2 ± 1.6 Gy) and both zones 1 and 3 received low-dose exposure
(24.4 ± 1.1 Gy), the observed mean numbers of RI-CMs were
6.6 ± 1.1 (median, 5.0) in zone 2, 1.3 ± 0.3 (median, 1.0) in zone 1
and 1.2 ± 0.3 (median, 1.0) in zone 3 (P < 0.000001). In the
reduced-field group, which received radiation only to zone 2, 52
(94.5%) of 55 RI-CM lesions were detected in zone 2. The mean
number of RI-CMs was 3.7 ± 0.9 (median, 2.5) in zone 2 as com-
pared with 0.1 ± 0.1 (median, 0) in zone 1 and 0.1 ± 0.1 (median,
0) in zone 3 (P < 0.001), revealing a difference between irradiated
and unirradiated areas. In addition, comparing zone 2 of the
whole-brain group with that of the reduced-field group, there
was a trend toward a higher number of RI-CMs in the whole-
brain group (mean, 6.6 versus 3.7; median, 5.0 versus 2.5), though
this difference did not reach statistical significance (P = 0.082).
During the observation period between 2006 and 2013, we
observed increases in the number of RI-CMs in some cases and
acute/subacute hemorrhage showing hyperintensities on T1WI in
three cases. One patient reported a severe headache with vomiting
12 h prior to undergoing MR imaging, which revealed an acute
hemorrhagic lesion in the splenium of the corpus callosum with
intraventricular rupture and subarachnoid hemorrhage (Supple-
mentary Fig. S1). As this lesion appeared in a location different
from the sites of preexisting RI-CMs, it was interpreted as an inter-
val appearance of a new RI-CM, followed by hemorrhage. In the
other two patients, MR images revealed asymptomatic subacute
hemorrhage (not shown).
Besides RI-CM, other radiological sequelae were also observed
in long-term survivors (Table 2). There were no significant differ-
ences between the whole-brain and reduced-field groups in terms
of the presence of cerebral infarction (P = 0.449), major artery
occlusion (P = 0.672), white matter T2 hyperintensities
(P = 0.378), brain atrophy (P = 0.080) or meningioma (P = 0.449).Discussion
We investigated radiation-induced cavernous malformations
(RI-CMs) in patients with intracranial GCT for a mean follow-up
period of 18.5 years after radiation treatment and compared effects
of whole-brain irradiation versus reduced-field irradiation based
on the number of developing lesions. The mean number of RI-
CMs per patient was 2.3 times as high in the whole-brain irradia-
tion group as in the reduced-field irradiation group (P = 0.00296)
Fig. 2. Case 1. Axial T2-weighted Gradient-echo (T2*GRE; 600/26 ms) MR image (a) and T2-weighted fast spin-echo (T2WI; 4240/96 ms) MR image (b) obtained in a 36-year-
old man with a history of intracranial GCT at a follow-up time of 23.7 years after extended-local irradiation in combination with whole-brain irradiation (total dose of 50 Gy).
Four RI-CM lesions showing very low signal intensity are visible on the T2*GRE image (a); however, these lesions were poorly visualized on a conventional T2WI image (b).
Fig. 3. Difference in the number of RI-CMs between whole-brain and reduced-field
groups demonstrates the effect of radiation field size on the extent of RI-CMs
development. The number of RI-CMs developing in the large-field irradiation
(whole-brain) group is significantly larger compared with that in the reduced-field
irradiation (reduced-field) group (P = 0.00296, Mann–Whitney U test). Bars are
SEM.
Fig. 4. Difference in the number of RI-CMs among zones in each group demon-
strates the effect of radiation dose on the number of RI-CMs developed. The number
of RI-CMs developed in the high-dose field (zone 2) is significantly larger compared
with that in the low-dose (zones 1 and 3 of the whole-brain group; P < 0.000001) or
untreated fields (zones 1 and 3 of the reduced-field group; P < 0.001); calculated
using Tukey’s HSD test. Bars are SEM.
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ferent between these groups (50.2 ± 1.6 Gy versus 53.5 ± 2.3 Gy;
P = 0.260). This indicates that a larger radiation field is associated
with a larger number of RI-CMs. It has been suggested that RI-
CMs reflect post-irradiation impairment of cerebral microcircula-
tion with preferential involvement of the venous endothelium,
with resultant veno-occlusive changes and induction of vascular
malformation [16,17,26]. Given that RI-CM is one indicator of
post-irradiation impairment of cerebral microcirculation, larger
radiation fields would be associated with a more extensive area
of impairment in cerebral microcirculation, possibly related to cog-
nitive decline reported in children undergoing whole-brain
irradiation.
Comparing zone 2 of the whole-brain group to that of the
reduced-field group, there was a trend toward a higher number
of RI-CMs in the whole-brain group. This trend might be related
to a difference in radiation fields between the zone 2 regions in
the two groups; the areas in front of and behind the ventricle in
zone 2 were included within the radiation field in the whole-
brain group, but not in the reduced-field group.
In some studies of radiation dose as a risk factor, investigators
found that patients that had received a higher dose of radiation
showed a shorter latency period for cavernous malformation
development in the treatment field [27]. Koike and colleagues
studied the relationship between radiation dose and prevalence
(presence or absence) of RI-CMs and found that the prevalence of
RI-CMs did not differ significantly between the high- and low-
dose radiation fields, despite a tendency to be higher in the field
of high-dose radiation [17]. We focused on the relationship
between radiation dose and extent (number) of RI-CMs and con-
firmed a positive relationship between these parameters; the num-
ber of RI-CMs in the high-dose field was significantly higher than in
the low-dose fields, which had never before been documented. The
increased number of cavernous malformations in high-dose fields
may argue for low-dose irradiation for germ cell tumors whenever
feasible.
Our results suggest that the risk of cerebral microvascular
injury associated with radiotherapy needs to be considered when
treatment is planned. This is especially true in cases of low-grade
tumors because the adverse effects of irradiation, especially late
sequelae, are of major concern considering the expected long sur-
vival of the patients. For treatment of intracranial GCTs, optimal
management of radiotherapy remains an important topic [3,28].
A radiation field encompassing the whole brain is still widely used
Table 2
Radiation-induced changes on MRI other than RI-CM.
Patient Cerebral
infarction*
Occlusion of major arteryy White matter T2
hyperintensities
Atrophy§ Meningioma
No Mild Severe
Whole-brain group (n = 20) 3 (15.0%) 3 (15.0%) 5 (25.0%) 6 (30.0%) 9 (45.0%) 5 (25.0%) 3 (15.0%)
Reduced-field group
(n = 14)
1 (7.1%) 2 (14.3%) 2 (14.3%) 9 (64.3%) 3 (21.4%) 2 (14.3%) 1 (7.1%)
P = 0.449 P = 0.672 P = 0.378 P = 0.080 P = 0.449
Note: Besides radiation-induced cavernous malformation (RI-CM), other radiological changes on MRI were also observed in long-term survivors of intracranial GCTs.
Differences in the MRI findings between whole-brain and reduced-field groups were assessed using the Fisher’s exact test or the Mann–Whitney U test.
* Lacunar infarctions were excluded.
y Presence or absence of major artery lesions was evaluated by MRA.
 All seven cases exhibited multifocal punctate-to-large flocculent T2 hyperintensities involving deep white matter.
§ Cortical atrophy was rated on a 3-grade scale (no = no atrophy; mild = mild widening of the sulci without evidence volume loss of the gyri; severe = substantial widening
of the sulci and volume loss of the gyri) [34,35].
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associated with an unacceptable relapse rate of about 15–40%
[6,8,30]; most of these reported relapses developed in periventric-
ular areas outside the radiation field [8]. To balance the trade-off
between optimal treatment outcome and long-term adverse
effects, chemotherapy followed by reduced-dose (24-Gy)
reduced-field (whole-ventricle) irradiation was proposed by the
Japanese Pediatric Brain Tumor Study Group [25,31]. With this
approach, most relapses were avoided [7,8] and no difference
was found in the 10-year overall survival rate following whole-
ventricle irradiation as compared with whole-brain irradiation
[7]. This guideline has been followed at our institution since
1997 [7] and patients who received whole-brain irradiation before
1997 were enrolled in the present study. To our knowledge, ours is
the first comparative radiological study based on the extent of
cerebral microvascular injury following whole-brain irradiation
versus reduced-field irradiation.
Our study showed a very high prevalence of RI-CMs (94.1%).
Most previous studies estimated the prevalence of RI-CMs as
between 1.2% and 56% [32]. The wide variation probably derives
from differences in MR imaging sequences, age at initial irradia-
tion, radiation dose received, length of follow-up interval and pres-
ence or absence of chemotherapy. In the study of Koike et al., in
which the prevalence of very-low-signal-intensity foci was 20%
in pediatric patients with various brain tumors at 4.2 years after
radiotherapy, the sequence employed was spin-echo or fast spin-
echo T2WI. In contrast, we used a T2*GRE sequence and a much
longer follow-up interval (18.5 years) in pediatric or young adult
cases of intracranial GCTs. This may explain the higher prevalence
that we observed.
A limitation of our study is that spontaneous cavernous malfor-
mations (not RI-CMs) might have been included in our RI-CMs
counts; these are indistinguishable on T2*GRE imaging. The exact
incidence of spontaneous cavernous malformation on T2*GRE
imaging is not known, though it was reported to be only 0.5–
0.7% by Zabramski et al., in a study using T2WI instead of
T2*GRE imaging [20,33]. This may have caused miscounting of
RI-CMs because baseline T2*GRE imaging before radiotherapy
was not obtained. In addition, though very-low-signal-intensity
foci in the basal ganglia (especially symmetric ones in the Globus
pallidus) and dentate nuclei were eliminated from the counting,
those in cortical/subcortical regions were counted as RI-CMs. Some
of these might have been mineralization foci instead of RI-CMs,
indicating another potential limitation of our study.
In conclusion, radiation-induced cerebral cavernous malforma-
tions occur with extraordinary frequency in long-term survivors of
cancer. We first demonstrated that the radiation field (whole-brain
versus reduced-field irradiation) and radiation dose (high- versus
low-dose) were associated with the number of cerebral cavernous
malformations detected, which reflects the extent of cerebralmicrocirculatory impairment and might influence neurocognitive
status in long-term survivors of these neoplasms. Our results help
to inform the balance between risks and benefits that guide treat-
ment decisions. T2-weighted gradient-echo sequence should be
included in routine MRI follow-ups to detect and evaluate cerebral
cavernous malformation, which can be used as a surrogate marker
for microvascular injury post-irradiation in cancer survivors.Conflict of interest statement
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